Pfizer Inc

Change company Symbol lookup

Select an option...

PFE Pfizer Inc

JGGC Jaguar Global Growth Corporation I

WHG Westwood Holdings Group Inc

BNOX Bionomics Ltd

PSO Pearson PLC

ERNA Eterna Therapeutics Inc

INDP Indaptus Therapeutics Inc

TSLX Sixth Street Specialty Lending Inc

WAVD Wavedancer Inc

SGBX Safe & Green Holdings Corp

Go

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) sank 0.03% to $32.09 Thursday, on what proved to be an all-around favorable trading session for the stock...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slipped 0.93% to $32.10 Wednesday, on what proved to be an all-around mixed trading session for the stock...(MarketWatch)

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.(Zacks)

Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates. In the collaboration, Pfizer will leverageGinkgo's proprietary RNA technology to advance the discovery and...(PR Newswire)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 1.76% to $32.40 Tuesday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

FinancialNewsMedia.com News Commentary - The Global Medical Device Packaging market is anticipated to continue its growth rate in several coming years. Medical device packaging applications employ various materials and methods. The packaging...(PR Newswire)

By Claudia Assis 'Some medicines may not be back in full supply until next year,' Pfizer says Pfizer Inc. said late Monday that it has restarted production at a North Carolina facility badly damaged by a tornado in July, but...(MarketWatch)

If this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved treatment for eosinophilic esophagitis in children aged 1 to 11. A final decision is expected in January.(Zacks)

In the latest trading session, Pfizer (PFE) closed at $32.98, marking a +0.89% move from the previous day.(Zacks)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) inched 0.89% higher to $32.98 Monday, on what proved to be an all-around positive trading session for the...(MarketWatch)

Pfizer's (PFE) Abrysvo has been recommended by the CDC for preventing RSV in infants by immunizing pregnant women, during weeks 32-36 of pregnancy.(Zacks)

Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.(Zacks)

Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.(Zacks)

By Charles Passy The shot, which guards against the current variants, is now available It may be time to get your COVID-19 vaccine again. There's a new shot that's now available to guard against the virus. The Centers...(MarketWatch)

By Eleanor Laise New shot aims to protect babies from a leading cause of hospitalization The Centers for Disease Control and Prevention on Friday recommended pregnant people get Pfizer Inc.'s (PFE) maternal vaccine to protect...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slipped 0.49% to $32.69 Friday, on what proved to be an all-around rough trading session for the stock market...(MarketWatch)

Pfizer Inc. (NYSE: PFE) shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) following a favorable vote for...(BusinessWire)

The European Commission approves Pfizer's (PFE) Litfulo for severe alopecia areata. FDA gives priority tag to Merck's (MRK) supplemental applications for Welireg and Keytruda.(Zacks)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 2.29% to $32.85 Thursday, on what proved to be an all-around dismal trading session for the stock market...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 1.09% to $33.62 Wednesday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)